SCHEMBL5082824

SCHEMBL5082824

Clc1ccc(C(OCCC2CCCCN2)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.53
SLC6A4 P31645 4/20 0.53
SLC6A3 Q01959 4/20 0.53
CYP3A4 P08684 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
TSHR P16473 1/20 0.53
CYP2C19 P33261 1/20 0.53
HIF1A Q16665 1/20 0.53
SLC22A1 O15245 1/20 0.53
CHRM2 P08172 1/20 0.53
HTR1A P08908 1/20 0.53
ADRA2A P08913 1/20 0.53
CHRM1 P11229 1/20 0.53
DRD1 P21728 1/20 0.53
TBXA2R P21731 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRM1 P35372 1/20 0.53
DRD3 P35462 1/20 0.53
KCNH2 Q12809 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5082818 0.88 CHRNA7 (0.49)
SCHEMBL11448671 0.74 LTA4H (0.68) LTA4H
SCHEMBL5190981 0.74 CYP3A4 (0.64) SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2
SCHEMBL4669314 0.74 CYP3A4 (0.64) SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2
SCHEMBL2841877 0.74 LTA4H (0.55) LTA4H
SCHEMBL2841875 0.74 LTA4H (0.55) LTA4H
SCHEMBL11447773 0.72 LTA4H (0.51) SLC6A2SLC6A4SLC6A3LTA4H
SCHEMBL11629768 0.72 POLB (0.56) CYP3A4CYP1A2CYP2D6CYP2C19HTR1A
SCHEMBL7446075 0.71 LTA4H (0.75) LTA4H
SCHEMBL4965391 0.71 LTA4H (0.64) SLC6A2SLC6A3LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133884-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-11-06 WO disclosed